Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

Ex Input:
Paragraph: According to the Maine Center for Disease Control, the number of syphilis cases reported in the state increased from 48 in 2016 to 84 last year. The number of national syphilis cases increased by 18 percent in between 2015 and 2016. Maine Department of Health and Human Services spokeswoman tells the Bangor Daily News the department isn’t sure why syphilis has increased in recent years. Portland Public Health Center medical director Dr. Christina DeMatteo believes opioid use and waning concerns about HIV have contributed to attitudes about having unprotected sex. Public health advocates say budget cuts resulting in changes in prevention and treatment have also affected rates in the state. ___ Information from: Bangor Daily News, http://www.bangordailynews.com Claim: Maine sees increase in reported syphilis cases.

Ex Output:
Public health officials in Maine say there has been an increase in syphilis cases, mirroring a national trend.


Ex Input:
Paragraph: "There is no mention of cost. The story could have at least reported what the drug costs in its current use against blood cancer. The story did a good job of explaining both the potential benefits and harms of the drugs. This was a particular strength of this story – and made it stand out in comparison with the LA Times blog story that we also reviewed. Harms were emphasized from the outset – even in the headline – in the AP story but were never mentioned in the LA Times story. And this story reminded readers of the side effects encountered with another MS drug, Tysabri. Outstanding job on this issue by the AP. The story did a very good job of explaining the studies. There is no sign of disease-mongering in this story. Two apparently independent sources were quoted. The story did a good job comparing the new drugs with existing approaches to treat MS. Story explains that the drug is already sold to treat a rare blood cancer and stated that ""it’s too soon to know if the pills will be approved by the government or widely adopted by physicians."" It does not report, however, as the LA TImes blog did, that ""The drug company MD Serono, an affiliate of Merck, has requested approval from the Food and Drug Administration to market the tablet. However it recently received a ""refuse to file"" letter from the FDA, which means the agency is requiring additional information or data. MD Serono said it is pursuing the matter with the FDA and hopes to re-submit its application."" We think that’s a crucial piece of information that affects availability, although, of course, doctors can still prescribe it for off-label use even before the FDA acts on the new request. The novelty of ""tests of the first two oral drugs developed for treating MS"" was clear in the story. It is clear that this story did not rely on a news release." Claim: MS pills show promise and risk, studies say

Ex Output:
Nice job explaining harms and benefits – including putting the potential risks/harms right in the headline. The appeal of an oral drug for MS is clear. The risks emphasized in this story, though, raise important questions


Ex Input:
Paragraph: The state Agriculture Department said in a news release that tests confirmed the presence of the H7 strain of Highly Pathogenic Avian Influenza, or HPAI, at a facility in Lincoln County. The facility alerted the state veterinarian’s office on Friday about an increase in chicken deaths. The statement did not name the facility. The facility and about 30 other poultry farms within about a six-mile radius of the site are under quarantine. “Animal health is our top priority,” said Dr. Charles Hatcher, the state veterinarian. “With this HPAI detection, we are moving quickly and aggressively to prevent the virus from spreading.” The U.S. Department of Agriculture said 73,500 chickens are in the facility’s flock. Officials said HPAI poses no risk to the food supply, and no affected chickens entered the food chain. According to the Centers for Disease Control and Prevention, HPAI can cause up to 100 percent mortality in flocks, often within 48 hours. “Many Tennessee families rely on the poultry industry for their livelihoods, and the state is working closely with local, county and federal partners and the poultry industry to control the situation and protect the flocks that are critical to our state’s economy,” Tennessee Gov. Bill Haslam said. According to the Tennessee Poultry Association, there are more than 1,650 commercial broiler and breeder houses on more than 550 family farms in the state. The state ranks 13th nationally in broiler production and processing with more than 6 million birds per week at five plants. The statement said the most recent U.S. detection of HPAI was in January 2016 in a commercial turkey flock in Indiana. More than 414,000 turkeys and chickens were euthanized to contain the outbreak. In 2015, U.S. poultry producers, primarily in the upper Midwest, lost more than 48 million birds to bird flu. Minnesota, the country’s top turkey producer, and Iowa, the top chicken-egg producer, were the hardest-hit states. Claim: Bird flu detected in chicken breeding facility in Tennessee.

Ex Output:

A commercial chicken breeding facility in south-central Tennessee has been hit by a strain of bird flu, agriculture officials said Sunday.